Activiomics develops phosphoproteomics solutions for biomarker discovery and drug candidate profiling.
Activiomics has raised €725k across 1 funding round, most recently a round in Mar 2011. Based in London, UK; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2011-03-01 | Other | €725k |
| — |
| View deal → |
